ARMC
DNA icon

American Research & Management Company’s Ginkgo Bioworks DNA Stock Holding History

American Research & Management Company’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2K Hold
18
– – ﹤0.01% 378
2022
Q2 		$2K Hold
18
– – ﹤0.01% 366
2022
Q1 		$3K Hold
18
– – ﹤0.01% 363
2021
Q4 		$6K Buy
+18
New +$8.55K ﹤0.01% 329

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

American Research & Management Company's DNA Position: Q3 2022 in Review

American Research & Management Company held its Ginkgo Bioworks (DNA) position steady in Q3 2022 at 18 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

American Research & Management Company first reported a position in DNA in Q4 2021 and has held it in 4 quarters since. The position peaked at $6K in Q4 2021. 278 funds tracked by Wall St. Rank hold DNA as of Q3 2022.

  • American Research & Management Company held 18 shares of Ginkgo Bioworks worth $2K as of Q3 2022.
  • American Research & Management Company left its Ginkgo Bioworks share count unchanged in Q3 2022.
  • Ginkgo Bioworks made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #378 holding.
  • American Research & Management Company first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 4 quarters since.
  • American Research & Management Company's Ginkgo Bioworks position peaked at $6K in Q4 2021.
  • 278 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.